Sort
48,018 grants matching “immunotherapy”
Mechanisms of the Induction of Oral Tolerance
$423,878Howard L Weiner · Brigham And Women'S Hospital · R01 · FY2014 · AI
Nanoscale Coordination Polymers of Cyclic-di-nucleotides and Peptide Antigens for Effective Therapy of Metastatic Colorectal Cancer
$423,829Ralph R Weichselbaum · University Of Chicago · R01 · FY2024 · CA
Clinical characterization of Kidney Injury Molecule-1 (KIM-1) as a Biomarker in Renal Cell Carcinoma
$423,811David McDermott · Beth Israel Deaconess Medical Center · R01 · FY2023 · CA
Pathogenesis of EBV Infection
$423,802Frederick C. Wang · Brigham And Women'S Hospital · R01 · FY2013 · CA
HIFU-enhanced tumor vaccines
$423,775Chandan Guha · Albert Einstein College Of Medicine · R01 · FY2009 · EB
Targeting ER+ Breast Cancer Through Induced Viral Mimicry
$423,760Charles H Spruck · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2024 · CA
KRAS inhibitors prime cancer cells for macrophage-mediated destruction
$423,760Kipp A Weiskopf · Whitehead Institute For Biomedical Res · R01 · FY2024 · CA
Targeting the FBXO44/SUV39H1 Pathway in Cancer
$423,760Charles H Spruck · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2024 · CA
Myeloid Specific Targeted Nanoimunotherapy for Organ Transplant Acceptance
$423,750Jordi Ochando · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · AI
Regulation and function of innate lymphoid cells in the gut
$423,750David Artis · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · AI
Epitope-Specific Targeting of Tau Aggregates.
$423,750Einar M Sigurdsson · New York University School Of Medicine · R01 · FY2020 · NS
Modulating Immunity through Dendritic Cell Phagocytic Receptors
$423,750Nina Bhardwaj · New York University School Of Medicine · R01 · FY2009 · AI
Regulation and function of innate lymphoid cells in the gut
$423,750David Artis · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · AI
Dissecting the influence of DNA damage response and homologous recombination deficiencies on tumor immunogenicity
$423,750Robert M Samstein · Icahn School Of Medicine At Mount Sinai · DP5 · FY2023 · OD
Contribution of the cutaneous APC network to melanoma progression and therapy.
$423,750Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2013 · CA
Epitope-Specific Targeting of Tau Aggregates.
$423,750Einar M Sigurdsson · New York University School Of Medicine · R01 · FY2019 · NS
Myeloid Specific Targeted Nanoimunotherapy for Organ Transplant Acceptance
$423,750Jordi Ochando · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · AI
Epitope-Specific Targeting of Tau Aggregates.
$423,750Einar M Sigurdsson · New York University School Of Medicine · R01 · FY2021 · NS
Contribution of the cutaneous APC network to melanoma progression and therapy.
$423,750Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · CA
Hiv Immune Reactivity 'in Vivo'and 'In Vitro'
$423,750Weill Medical College Of Cornell Univ · R01 · FY2003 · AI
Contribution of the cutaneous APC network to melanoma progression and therapy.
$423,750Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · CA
Novel mechanisms regulating PD-1 signaling and function
$423,750Adam Mor · New York University School Of Medicine · R01 · FY2016 · AI
Hiv Immune Reactivity 'in Vivo'and 'In Vitro'
$423,750Weill Medical College Of Cornell Univ · R01 · FY2005 · AI
Regulation and function of innate lymphoid cells in the gut
$423,750David Artis · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · AI
In vivo role of CTLA-4 in Costimulation and Autoimmunity
$423,750Arlene H Sharpe · Harvard Medical School · R01 · FY2016 · AI